115 related articles for article (PubMed ID: 5715725)
21. [Zone-electrophoretic, chromatographic and spectrographic studies on fibrinogens of normal and cobalt treated rabbits].
Krantz S; Fiedler H; Lober M
Acta Biol Med Ger; 1970; 25(4):523-37. PubMed ID: 5518786
[No Abstract] [Full Text] [Related]
22. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
[TBL] [Abstract][Full Text] [Related]
23. The effects of infusing thrombin and its acetylated derivative. I. Studies of coagulation and fibrinolysis.
Pechet L; Engel AM; Goldstein C; Glaser B
Thromb Diath Haemorrh; 1968 Nov; 20(1):190-201. PubMed ID: 5751381
[No Abstract] [Full Text] [Related]
24. [Effect of oligomer cations on blood coagulation].
Herre V; Frimmer M
Thromb Diath Haemorrh; 1968 Nov; 20(1):227-33. PubMed ID: 5751382
[No Abstract] [Full Text] [Related]
25. [LIVER AND BLOOD COAGULATION. II. ANTITHROMBIN AND ANTITHROMBOPLASTIN ACTIVITY IN LIVER PATIENTS].
SOARDI F; BOLANDRINA E
Gazz Int Med Chir; 1964 Jan; 68():185-93. PubMed ID: 14154378
[No Abstract] [Full Text] [Related]
26. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.
Zürcher M; Sulzer I; Barizzi G; Lämmle B; Alberio L
Thromb Haemost; 2008 Feb; 99(2):416-26. PubMed ID: 18278194
[TBL] [Abstract][Full Text] [Related]
27. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
28. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
29. [Effect of thymalin on blood coagulation and fibrinolysis].
Kuznik BI; Budazhapova DTs; Zagrebina LA; Morozov VG; Khavinson VKh
Farmakol Toksikol; 1981; 44(4):422-5. PubMed ID: 7286199
[TBL] [Abstract][Full Text] [Related]
30. [Biological half-life of 131 I-labeled fibrinogen from normal and cobalt-treated rabbits].
Krantz S; Lober M; Oppermann P
Acta Biol Med Ger; 1972; 29(6):805-10. PubMed ID: 4659761
[No Abstract] [Full Text] [Related]
31. Effects of thorium dioxide upon blood clotting and platelets. II. In vivo studies in rabbits.
McGehee WG; Hjort PF; Rapaport SI
Thromb Diath Haemorrh; 1966 Dec; 16(3):354-70. PubMed ID: 5998918
[No Abstract] [Full Text] [Related]
32. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
34. Assay of progressive antithrombin in plasma.
Abildgaard U; Gravem K; Godal HC
Thromb Diath Haemorrh; 1970 Oct; 24(1):224-9. PubMed ID: 5483962
[No Abstract] [Full Text] [Related]
35. Influence of coagulation factors on intrinsic thrombin generation.
Stief TW; Otto S; Renz H
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):67-71. PubMed ID: 17179830
[TBL] [Abstract][Full Text] [Related]
36. Interspecies differences in coagulation profile.
Siller-Matula JM; Plasenzotti R; Spiel A; Quehenberger P; Jilma B
Thromb Haemost; 2008 Sep; 100(3):397-404. PubMed ID: 18766254
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of antithrombin administration in the acute phase of burn injury.
Lavrentieva A; Kontakiotis T; Bitzani M; Parlapani A; Thomareis O; Scourtis H; Tsotsolis N; Lazaridis L; Giala MA
Thromb Haemost; 2008 Aug; 100(2):286-90. PubMed ID: 18690349
[TBL] [Abstract][Full Text] [Related]
39. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
Kudrjashov BA; Pastorova VE; Lyapina LA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
[TBL] [Abstract][Full Text] [Related]
40. The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation.
Ramjee MK
Anal Biochem; 2000 Jan; 277(1):11-8. PubMed ID: 10610684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
